Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF

Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF

Pharmaceutical company Gilead Sciences has come under mounting pressure after refusing to sell its breakthrough HIV prevention drug, lenacapavir, directly to Médecins Sans Frontières (MSF), despite repeated requests.

MSF wants to buy groundbreaking HIV prevention drug. Why won’t Gilead sell? | Doctors Without Borders / Médecins Sans Frontières (MSF ...

Blocking humanitarian organizations from accessing a medical breakthrough puts people who are vulnerable across the world in danger.  Doctors Without Borders/Médecins Sans Frontières (MSF) sent an open letter to the U.S. pharmaceutical corporation Gilead Sciences on March 30, calling on the company to immediately sell to MSF, lenacapavir, an HIV medicine that is one of the most important advances in HIV prevention in decades.  About 1.3 million …

Africa: Gilead Refuses to Sell Groundbreaking HIV Prevention Drug to MSF

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger. In an open letter published today, Doctors Without Borders/Médecins Sans Frontières (MSF) called on the US pharmaceutical corporation Gilead Sciences to immediately sell the organization the game-changing and highly effective HIV prevention medicine, lenacapavir, for use in its medical programs worldwide. Despite multiple …